FMO5 and type 1 diabetes mellitus: In line herewith, in a similar STZ‐induced type 1 diabetes rat model Liraglutide was shown to normalise DM‐induced myocardial NAD(P)H oxidase activity, oxidative stress markers and apoptosis, without affecting plasma glucose and insulin levels.27, 28